M Charon
Impact in
- Hematology top 2%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 10
- Platelet Disorders and Treatments 5
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Isabelle Dusanter‐Fourt (10 shared papers)Fabrice Wendling (9 shared papers)P Tambourin (6 shared papers)Sylvie Gisselbrecht (7 shared papers)P. Varlet (4 shared papers)Marie-Christine Rouyez (3 shared papers)David Cosman (2 shared papers)Najet Debili (2 shared papers)
In The Last Decade
M Charon
20 papers receiving 882 citations
Peers
Comparison fields: 5 of 56
- Hematology 515
- Genetics 191
- Immunology 184
- Oncology 224
- Immunology and Allergy 42
Countries citing papers authored by M Charon
This map shows the geographic impact of M Charon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Charon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Charon more than expected).
Fields of papers citing papers by M Charon
This network shows the impact of papers produced by M Charon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Charon. The network helps show where M Charon may publish in the future.
Co-authors
The 25 scholars most cited alongside M Charon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 237 | |
| 2 | 1995 | 112 | |
| 3 | 1986 | 109 | |
| 4 | 1996 | 80 | |
| 5 | 2003 | 73 | |
| 6 | 2005 | 53 | |
| 7 | Expression and activation of B-Raf kinase isoforms in human and murine leukemia cell lines. | 1995 | 39 |
| 8 | 2004 | 35 | |
| 9 | Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. | 1990 | 27 |
| 10 | 1989 | 26 | |
| 11 | 1994 | 25 | |
| 12 | 1995 | 24 | |
| 13 | 1995 | 15 | |
| 14 | 1974 | 12 | |
| 15 | The 'WS motif' common to v-mpl and members of the cytokine receptor superfamily is dispensable for myeloproliferative leukemia virus pathogenicity. | 1993 | 10 |
| 16 | 2002 | 9 | |
| 17 | 1981 | 7 | |
| 18 | 1989 | 5 | |
| 19 | 1995 | 5 | |
| 20 | 1989 | 3 |
About M Charon
M Charon is a scholar working on Hematology, Molecular Biology, Immunology, Oncology and Pathology and Forensic Medicine, having authored 20 papers that have together received 906 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Platelet Disorders and Treatments (5 papers), Cytokine Signaling Pathways and Interactions (3 papers), Acute Myeloid Leukemia Research (3 papers), Virus-based gene therapy research (3 papers), Erythrocyte Function and Pathophysiology (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (515 citations), Genetics (191 citations), Immunology (184 citations), Oncology (224 citations) and Immunology and Allergy (42 citations). M Charon has collaborated with scholars based in France, Belgium and Canada. Frequent co-authors include Isabelle Dusanter‐Fourt, Fabrice Wendling, P Tambourin, Sylvie Gisselbrecht, P. Varlet, Marie-Christine Rouyez, David Cosman, Najet Debili, Ken Schooley and Matthias Titeux. Their work appears in journals such as Blood, Journal of Virology, Molecular and Cellular Biology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.